Horn & Co. represented Nanosynex Ltd. in the deal. Qualigen Therapeutics, Inc. has completed the acquisition of a majority stake in NanoSynex Ltd., an Israeli-based developer...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here